Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights: How Understanding Consumer Behavior Can Lead to Market Success
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market size was valued at USD 1.4 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 8.0% from 2024 to 2030. Key Market Insights on the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Trends, Challenges, and Growth Opportunities […]
Continue Reading